We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
226
Next Financial Group
Texas
– -$37K -172 Closed
RFA
227
Reilly Financial Advisors
California
– -$35K -160 Closed
PWMG
228
Prestige Wealth Management Group
New Jersey
– -$32K -149 Closed
GSAM
229
Grant Street Asset Management
Pennsylvania
– -$32K -146 Closed
WAP
230
Wealthcare Advisory Partners
Pennsylvania
– -$31K -142 Closed
NFSG
231
Newbridge Financial Services Group
Florida
– -$30K -140 Closed
SIS
232
Sound Income Strategies
Florida
– -$30.4K -140 Closed
ED
233
Exane Derivatives
France
– -$29.9K -138 Closed
FFC
234
First Financial Corp
Indiana
– -$29K -135 Closed
CFFP
235
Center for Financial Planning
Michigan
– -$28K -128 Closed
GEA
236
Glen Eagle Advisors
New Jersey
– -$26.9K -124 Closed
MSFP
237
Mark Sheptoff Financial Planning
Connecticut
– -$26K -120 Closed
KLWA
238
Kelly Lawrence W & Associates
California
– -$25K -115 Closed
RIM
239
Rockbridge Investment Management
New York
– -$24K -112 Closed
CHA
240
Carmichael Hill & Associates
Maryland
– -$24K -109 Closed
FCA
241
FinTrust Capital Advisors
South Carolina
– -$23K -105 Closed
SOW
242
State of Wyoming
Wyoming
– -$22K -103 Closed
FEG
243
Financial Enhancement Group
Indiana
– -$22K -100 Closed
FHC
244
First Horizon Corporation
Tennessee
– -$21K -100 Closed
MAWCM
245
Mine & Arao Wealth Creation & Management
California
– -$22K -100 Closed
OIA
246
Optimum Investment Advisors
Illinois
– -$22K -100 Closed
RWB
247
RMR Wealth Builders
New Jersey
– -$22K -100 Closed
CFA
248
Carroll Financial Associates
North Carolina
– -$20K -94 Closed
Bessemer Group
249
Bessemer Group
New Jersey
– -$18K -83 Closed
BBHC
250
Brown Brothers Harriman & Co
New York
– -$16 -72 Closed
8 9
10
11 12

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.